FDA Clearance Tracker · P960009-S545
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Nov 8, 2026
Approved
Time to decision
90 days
Received Aug 10, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Real-Time Process
Device class
Class III
The decision
- FDA number
- P960009-S545
- Device name
- Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Aug 10, 2026
- Decided
- Nov 8, 2026
- Decision
- Approved
- Supplement type
- Real-Time Process
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for dimensions size change for lead insertion tool and modification to tip width dimension verification testing.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.